Cite
APA Citation
Wei, X. X., Siegel, A. P., Aggarwal, R., Lin, A. M., Friedlander, T. W., Fong, L., Kim, W., Louttit, M., Chang, E., Zhang, L., & Ryan, C. J. (2018). a Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer. Oncologist, 23, 656–e64. http://access.bl.uk/ark:/81055/vdc_100066471096.0x00002f